Complete Filing Data
Genvor Inc reported Stockholders Equity of -$1.70 million for FY2023.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Genvor Inc did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Net Income Loss | -$5.6M | -$2.9M | -$1.7M | -$3.4M | -$4.9K | -$6.0K |
| Operating Expenses | $6.4M | $2.8M | $1.4M | $3.1M | $4.9K | $6.0K |
| Operating Income Loss | -$6.4M | -$2.8M | -$1.4M | -$3.1M | ||
| Nonoperating Income Expense | $820.8K | -$101.9K | -$268.8K | |||
| Interest Expense | $59.8K | $17.7K | $43.8K | |||
| Selling General And Administrative Expense | $23.8K | $4.9K | $6.0K | |||
| Revenues | $0.00 | $0.00 | $0.00 | |||
| Research And Development Expense | $455.9K | $240.3K | $82.5K | $226.4K | ||
| Other General And Administrative Expenses | $131.1K | $69.8K | -$87.7K | |||
| Income Taxes Paid | $0.00 | $0.00 | $0.00 | |||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$5.6M | -$2.9M | -$1.7M | |||
| Operating Expenses Paid By Shareholder | $0.00 | $870.00 | $0.00 | |||
| Other General And Administrative Expense | $171.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$576.3K | -$397.8K | -$299.0K | -$5.0M | -$601.9K | -$772.1K | -$1.4M | -$215.0K | -$221.2K | -$179.6K | -$687.7K | -$3.3M | -$515.7K | -$617.4K | $0.00 | $0.00 | -$870.00 | $0.00 | $0.00 | $0.00 | |
| Operating Expenses | $562.7K | $577.5K | $276.1K | $5.0M | $571.8K | $747.4K | $1.3M | $149.1K | $155.3K | $113.7K | $645.5K | $3.2M | $453.3K | $565.2K | $0.00 | $0.00 | $870.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income Loss | -$562.7K | -$577.5K | -$276.1K | -$5.0M | -$571.8K | -$747.4K | -$1.3M | -$149.1K | -$155.3K | -$113.7K | -$645.5K | -$3.2M | -$453.3K | -$565.2K | |||||||
| Nonoperating Income Expense | -$13.6K | $179.8K | -$22.9K | -$3.8K | -$30.0K | -$24.7K | -$46.4K | -$66.0K | -$65.9K | -$66.0K | -$42.2K | -$63.2K | -$57.8K | ||||||||
| Interest Expense | $15.0K | $16.1K | $22.9K | $3.8K | $481.00 | $16.4K | $5.8K | $5.8K | $5.8K | $12.2K | $33.2K | ||||||||||
| Selling General And Administrative Expense | $60.0K | $10.0K | $5.2K | $53.4K | $0.00 | $0.00 | $870.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||
| Revenues | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||
| Research And Development Expense | $57.1K | $271.8K | $54.8K | $63.4K | $43.8K | $6.1K | $27.0K | $0.00 | $0.00 | $102.8K | $6.4K | $0.00 | |||||||||
| Other General And Administrative Expenses | $34.9K | $40.5K | $23.4K | $9.4K | $15.9K | $26.5K | $15.2K | $58.9K | $68.9K | -$36.2K | |||||||||||
| Income Taxes Paid | $0.00 | $0.00 | $0.00 | ||||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$576.3K | -$397.8K | -$299.0K | -$5.0M | -$601.9K | -$772.1K | -$1.4M | -$215.0K | |||||||||||||
| Operating Expenses Paid By Shareholder | |||||||||||||||||||||
| Other General And Administrative Expense | $15.9K | $35.4K | $68.8K | $59.5K | $140.7K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$1.7M | -$1.4M | -$1.6M | -$15.8K | -$9.8K | |||
| Common Stock Value | $20.0K | $19.1K | $38.7K | $26.0K | $20.0K | $20.0K | ||
| Retained Earnings Accumulated Deficit | -$20.6M | -$17.7M | -$16.0M | -$11.8M | -$40.7K | -$35.8K | ||
| Liabilities Current | $1.7M | $1.8M | $1.6M | $2.4M | $17.3K | $15.8K | ||
| Liabilities And Stockholders Equity | $35.6K | $82.1K | $316.0K | $556.9K | $0.00 | $0.00 | ||
| Assets | $35.6K | $82.1K | $316.0K | $556.9K | $0.00 | $0.00 | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $44.4K | $296.4K | $148.0K | |||||
| Liabilities | $1.7M | $1.8M | $1.7M | $2.8M | ||||
| Assets Current | $21.7K | $66.3K | $298.4K | $536.0K | ||||
| Property Plant And Equipment Net | $13.9K | $15.7K | $17.6K | $18.9K | ||||
| Accrued Liabilities Current | $9.8K | $302.0K | $6.0K | $12.0K | ||||
| Loans Payable Current | $48.8K | $48.8K | $48.8K | |||||
| Convertible Notes Payable Current | $7.4K | $500.0K | $1.1M | |||||
| Cash And Cash Equivalents At Carrying Value | $0.00 | |||||||
| Accounts Payable And Accrued Liabilities Current | $303.3K | $270.2K | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $384.6K | |||||||
| Late Fee Capitalized Into Notes Payable | $90.0K | $120.0K | $120.0K | |||||
| Cash | $0.00 | |||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $36.9K | -$44.0K | -$252.0K | |||||
| Accounts Payable Current | $516.7K | $571.2K | $7.5K | $0.00 | ||||
| Amortization Of Debt Discount Premium | $12.6K | $741.00 | $11.7K | |||||
| Treasury Stock Value | $300.0K | $300.0K | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $236.6K | |||||||
| Notes Payable Current | $897.0K | $819.5K | $1.1M | $1.6M | ||||
| Capital Contribution From Shareholder To Pay Accrued Expenses Note5 | $3.4K | $0.00 | ||||||
| Liabilities Noncurrent | $89.2K | $344.2K | ||||||
| Accrued Expenses Paid By Shareholder | $13.5K | $3.4K | ||||||
| Other Assets Current | $2.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$1.1M | -$1.3M | -$1.6M | -$2.1M | -$1.8M | -$1.7M | -$1.6M | -$1.1M | -$1.2M | -$1.8M | -$1.6M | -$1.4M | -$1.1M | -$2.0M | -$2.0M | -$62.5K | -$2.0M | -$3.8K | -$17.3K | -$13.3K | -$15.8K | -$15.8K | -$15.8K | -$9.8K | ||||
| Common Stock Value | $34.2K | $29.9K | $29.5K | $25.2K | $24.9K | $20.2K | $20.1K | $19.8K | $18.6K | $18.4K | $18.4K | $37.3K | $20.0K | $24.5K | $20.0K | $20.0K | $20.0K | $114.8K | $20.0K | $20.0K | ||||||||
| Retained Earnings Accumulated Deficit | -$26.8M | -$26.2M | -$26.3M | -$25.9M | -$25.6M | -$20.4M | -$19.8M | -$19.1M | -$16.9M | -$16.7M | -$16.5M | -$15.8M | -$79.7K | -$11.3M | -$40.7K | -$40.7K | -$40.7K | -$36.7K | -$35.8K | |||||||||
| Liabilities Current | $1.2M | $1.4M | $1.7M | $2.1M | $1.9M | $1.6M | $1.1M | $1.4M | $1.8M | $1.8M | $1.7M | $1.6M | $42.9K | $2.2M | $3.8K | $3.8K | $11.3K | $13.3K | $15.8K | |||||||||
| Liabilities And Stockholders Equity | $145.7K | $45.8K | $116.4K | $21.0K | $26.0K | $23.6K | $33.7K | $240.4K | $17.8K | $33.6K | $119.0K | $455.4K | $0.00 | $247.1K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Assets | $145.7K | $45.8K | $116.4K | $21.0K | $26.0K | $23.6K | $33.7K | $240.4K | $17.8K | $33.6K | $119.0K | $455.4K | $0.00 | $247.1K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $103.6K | $37.2K | $98.9K | $641.00 | $581.00 | $373.00 | $141.00 | $8.9K | $207.6K | $100.00 | $86.5K | $435.4K | $384.6K | $7.3K | $61.6K | $103.5K | ||||||||||||
| Liabilities | $1.2M | $1.4M | $1.7M | $2.1M | $1.9M | $1.6M | $1.1M | $1.4M | $2.0M | $1.9M | $1.8M | $1.9M | $2.7M | |||||||||||||||
| Assets Current | $145.7K | $45.8K | $103.9K | $8.1K | $12.6K | $9.2K | $18.9K | $225.1K | $1.6K | $16.9K | $101.9K | $435.4K | $225.7K | |||||||||||||||
| Property Plant And Equipment Net | $12.5K | $13.0K | $13.4K | $14.4K | $14.8K | $15.3K | $16.2K | $16.7K | $17.1K | $18.0K | $19.4K | |||||||||||||||||
| Accrued Liabilities Current | $70.0K | $57.0K | $42.7K | $29.9K | $87.3K | $58.6K | $35.0K | $122.2K | $0.00 | $0.00 | $0.00 | $9.5K | ||||||||||||||||
| Loans Payable Current | $48.8K | $48.8K | $48.8K | $48.8K | $48.8K | $48.8K | $48.8K | $48.8K | $48.8K | $48.8K | $48.8K | |||||||||||||||||
| Convertible Notes Payable Current | $20.0K | $17.4K | $14.1K | $10.7K | $867.0K | $1.0M | $1.2M | $1.2M | $1.1M | $300.0K | $0.00 | |||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | $247.9K | $366.9K | $206.7K | $321.4K | $181.0K | $317.4K | $388.8K | $134.0K | $302.3K | $239.1K | $12.0K | $12.0K | ||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $8.9K | $207.6K | $44.4K | $100.00 | $1.5K | $86.5K | $296.4K | $435.4K | $225.3K | $72.3K | ||||||||||||||||||
| Late Fee Capitalized Into Notes Payable | $458.00 | $30.0K | ||||||||||||||||||||||||||
| Cash | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $66.3K | $208.00 | $163.3K | -$209.9K | ||||||||||||||||||||||||
| Accounts Payable Current | $14.4K | $5.5K | $33.3K | $0.00 | $0.00 | $7.5K | ||||||||||||||||||||||
| Amortization Of Debt Discount Premium | $3.3K | $30.1K | ||||||||||||||||||||||||||
| Treasury Stock Value | $300.0K | $300.0K | $300.0K | $300.0K | $300.0K | $300.0K | $300.0K | $300.0K | ||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$209.9K | $377.3K | ||||||||||||||||||||||||||
| Notes Payable Current | $680.0K | $897.0K | $897.0K | $897.0K | $1.0M | $1.4M | ||||||||||||||||||||||
| Capital Contribution From Shareholder To Pay Accrued Expenses Note5 | $0.00 | $6.0K | $0.00 | |||||||||||||||||||||||||
| Liabilities Noncurrent | $179.6K | $149.4K | $119.3K | |||||||||||||||||||||||||
| Accrued Expenses Paid By Shareholder | $6.0K | |||||||||||||||||||||||||||
| Other Assets Current | $1.5K | $15.4K | $15.4K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$555.7K | -$975.6K | -$864.6K | -$663.2K | $0.00 | $0.00 |
| Net Cash Provided By Used In Financing Activities | $592.6K | $931.7K | $612.5K | $899.9K | $0.00 | $0.00 |
| Share Based Compensation | $4.9M | $1.4M | $962.9K | $2.2M | $1.1M | |
| Proceeds From Issuance Of Common Stock | $525.0K | $911.6K | $362.5K | |||
| Increase Decrease In Prepaid Expense | -$12.7K | -$670.00 | $22.0K | $1.3K | ||
| Proceeds From Notes Payable | $250.0K | $365.0K | ||||
| Net Cash Provided By Used In Investing Activities | $0.00 | $0.00 | $0.00 | |||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $122.9K | -$236.4K | -$304.4K | $13.5K | $3.4K | |
| Increase Decrease In Other Current Assets | -$2.0K | $0.00 | ||||
| Increase Decrease In Accounts Payable | $7.6K | $7.5K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q4 2024 | Q1 2024 | Q4 2023 | Q4 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q2 2021 | Q4 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$193.7K | -$1.4K | -$415.3K | -$409.9K | -$227.1K | $0.00 | $0.00 | ||||
| Net Cash Provided By Used In Financing Activities | $260.0K | $1.7K | $578.6K | $200.0K | $604.4K | $0.00 | $0.00 | ||||
| Share Based Compensation | $125.0K | $4.7M | $406.3K | $907.1K | $502.9K | $3.0M | $200.0K | $400.0K | |||
| Proceeds From Issuance Of Common Stock | $260.0K | $578.6K | $150.0K | $570.0K | |||||||
| Increase Decrease In Prepaid Expense | $33.6K | -$9.3K | -$4.5K | -$2.1K | |||||||
| Proceeds From Notes Payable | $50.0K | $34.4K | |||||||||
| Net Cash Provided By Used In Investing Activities | $0.00 | $0.00 | $0.00 | ||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $7.2K | $9.3K | -$26.4K | -$1.1K | $23.0K | ||||||
| Increase Decrease In Other Current Assets | $13.4K | -$55.7K | |||||||||
| Increase Decrease In Accounts Payable |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.22 | -$0.15 | -$0.09 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 20.0M | 19.1M | 38.7M | 26.0M | 20.0M | 20.0M | |
| Preferred Stock Shares Authorized | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | |
| Common Stock Shares Issued | 19.1M | 38.7M | 26.0M | 20.0M | 20.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Shares Outstanding Basic | 19.9M | 19.5M | |||||
| Earnings Per Share Basic | $-0.15 | $-0.09 | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 25.7M | 19.9M | 19.5M | ||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 20.0M | 20.0M | 20.0M | ||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.02 | -$0.01 | -$0.01 | -$0.24 | -$0.03 | -$0.04 | -$0.07 | -$0.01 | -$0.01 | -$0.01 | -$0.02 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Common Stock Shares Outstanding | 34.4M | 30.2M | 29.8M | 24.9M | 24.9M | 20.2M | 20.1M | 19.8M | 18.6M | 18.4M | 18.4M | 37.3M | 20.0M | 24.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | |||||||
| Preferred Stock Shares Authorized | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | |||||||
| Common Stock Shares Issued | 34.4M | 30.2M | 29.8M | 24.9M | 24.9M | 20.0M | 20.2M | 20.1M | 19.8M | 18.6M | 18.4M | 18.4M | 37.3M | 20.0M | 24.0M | 20.0M | 20.0M | 20.0M | 230.0K | 20.0M | 20.0M | |||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | |||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Weighted Average Number Of Shares Outstanding Basic | 32.8M | 27.5M | 24.9M | 20.7M | 20.2M | 19.7M | 19.4M | 18.5M | 18.4M | 22.5M | 36.4M | 20.0M | 20.0M | |||||||||||||
| Earnings Per Share Basic | $-0.02 | $-0.01 | $-0.01 | $-0.24 | $-0.03 | $-0.04 | $-0.07 | $-0.01 | $-0.01 | $-0.01 | $-0.02 | $-0.16 | $-0.03 | |||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 32.8M | 27.5M | 24.9M | 20.7M | 20.2M | 19.7M | 19.4M | 18.5M | 18.4M | 22.5M | 36.4M | |||||||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | ||||||||||||||||
| Preferred Stock Shares Outstanding | 9.00 | 9.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Preferred Stock Shares Issued | 9.00 | 9.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $19.2M | $16.3M | $14.6M | $9.5M | $3.4K | $0.00 | |
| Professional Fees | $320.4K | $1.1M | $672.1K | $89.6K | |||
| Stock Issued During Period Value Issued For Services | $100.0K | $356.3K | $2.5K | ||||
| Depreciation | $1.4K | $1.8K | $1.8K | ||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $48.1K | $25.0K | |||||
| Labor And Related Expense | $171.9K | $390.0K | |||||
| Penalties | -$120.0K | ||||||
| Prepaid Expense Current | $21.3K | $22.0K | $0.00 | $1.3K | |||
| Stock Issued During Period Value New Issues | |||||||
| Interest Paid | $0.00 | $0.00 | $0.00 | ||||
| Due To Related Parties Current | $0.00 | $0.00 | $3.8K | ||||
| Marketing And Advertising Expense | $4.5K | $84.2K | $0.00 | ||||
| Compensation And Related Benefits | $5.5M | $1.3M | $771.9K | ||||
| Sale Of Stock Consideration Received On Transaction | $911.6K | $362.5K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q2 2020 | Q1 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $26.0M | $25.1M | $25.0M | $24.1M | $24.0M | $19.2M | $19.0M | $18.2M | $14.9M | $14.8M | $14.8M | $14.3M | $16.9K | $8.8M | $16.9K | $16.9K | $9.4K | $3.4K | $0.00 | |||
| Professional Fees | $191.2K | $80.4K | $8.5K | $11.6K | $264.8K | $355.2K | $661.6K | $59.8K | $58.9K | $6.8K | $45.2K | $79.5K | $8.3K | $14.3K | ||||||||
| Stock Issued During Period Value Issued For Services | $110.0K | $62.5K | $62.5K | $4.9M | $50.0K | $306.3K | $502.5K | $3.0M | $200.0K | |||||||||||||
| Depreciation | $458.00 | $458.00 | $458.00 | $458.00 | $458.00 | $458.00 | $458.00 | |||||||||||||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $210.0K | $48.1K | $12.5K | $337.6K | ||||||||||||||||||
| Labor And Related Expense | $70.0K | $37.5K | $37.5K | $37.5K | $37.5K | $45.7K | $97.5K | |||||||||||||||
| Penalties | -$30.0K | -$30.0K | -$30.0K | -$30.0K | -$30.0K | -$30.0K | -$30.0K | $30.0K | ||||||||||||||
| Prepaid Expense Current | $42.2K | $8.6K | $5.0K | $7.4K | $12.0K | $9.1K | $10.0K | $17.5K | $0.00 | $3.4K | ||||||||||||
| Stock Issued During Period Value New Issues | $85.0K | $248.0K | $578.6K | $75.0K | $12.5K | $150.0K | $25.0K | $140.0K | $737.5K | |||||||||||||
| Interest Paid | $0.00 | $0.00 | $0.00 | |||||||||||||||||||
| Due To Related Parties Current | $3.8K | $3.8K | $33.5K | $16.2K | $3.8K | $3.8K | $3.8K | $3.8K | $3.8K | |||||||||||||
| Marketing And Advertising Expense | $6.4K | $0.00 | $0.00 | $3.8K | $12.9K | $11.7K | $17.7K | $0.00 | ||||||||||||||
| Compensation And Related Benefits | $273.0K | $184.8K | $189.4K | $4.9M | $234.4K | $348.0K | $583.5K | $54.0K | ||||||||||||||
| Sale Of Stock Consideration Received On Transaction | $85.0K | $248.0K | $578.6K | $75.0K | $12.5K | $150.0K |
Most recent annual filing with the SEC: December 10, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.